Contact Us: 1-800-981-9883
As 2023 draws to a close, we reflect on the successes of the year and the possibilities of the future. COLA is immersed in not only the continued focus on high quality laboratory results, but also the future of the laboratory industry. Our commitment to excellence is reinforced by our ongoing collaboration with the Workforce…
On December 13, 2023, the CDC issued a laboratory advisory and health alert regarding the Rocky Mountain Spotted Fever outbreak among travelers from Tecate, Mexico.
On December 7, 2023, the CDC issued a laboratory advisory and health alert for Monkeypox cases in the Democratic Republic of the Congo. For more information please visit this link.
On December 11, 2023, the CDC issued a laboratory advisory providing clinical testing guidance for patients with suspected viral hemorrhagic fevers (VHFs). The CDC advises that although the likelihood of VHFs being carried to the United States by travelers is minimal, they urge all laboratory personnel to carefully examine the guidance.
The Complex World of Viral Hemorrhagic Fevers Viral hemorrhagic fevers (VHFs) represent a diverse spectrum of diseases impacting both animals and humans. VHFs are caused by five distinct families of RNA viruses: Filoviridae, Flaviviridae, Rhabdoviridae, Arenaviridae and Hantaviridae. These conditions manifest a wide range of symptoms, often marked by bleeding or hemorrhaging. The disease can…
Welcome to the final part of our series on Gain of Function Research (GOFR). This chapter highlights the National Science Advisory Board for Biosecurity’s (NSABB) newest recommendations, which seek to mitigate biosecurity and biosafety risks while advancing crucial research on potential pandemic pathogens. The COVID-19 pandemic, with conjectures about a potential laboratory leak, has reinvigorated…
COLA, a physician-directed organization whose purpose is to promote health and safety through accreditation and educational programs, is announcing the hiring of Jeannie St. Pierre as the new Director of Business Development. Jeannie St. Pierre brings with her a wealth of experience in anatomic and clinical pathology laboratories spanning over 25 years. Jeannie’s impressive career…
Welcome back to the fourth installment of our series focusing on Gain of Function Research (GOFR). In this entry, we turn our spotlight onto the current oversight frameworks in the United States designed to mitigate the biosecurity and biosafety risks inherent in GOFR. The Maze of U.S. Regulatory Policies on GOFR The United States boasts…
In this resource you will learn how to develop and implement an effective Quality Assessment Plan which:
